Updated results of a phase III randomized, controlled study of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukemia (CLL).

被引：11
|
作者：
Jones, Jeffrey Alan
Robak, Tadeusz
Wach, Malgorzata
Brown, Jennifer R.
Menter, Alexander R.
Vandenberghe, Elizabeth
Ysebaert, Loic
Wagner-Johnston, Nina D.
Polikoff, Jonathan
Awan, Farrukh Tauseef
Badoux, Xavier Camille Albert
Coutre, Steven
Spurgeon, Stephen Edward Forbes
Loscertales, Javier
Dreiling, Lyndah
Xing, Guan
Peterman, Sissy
Dubowy, Ronald L.
Flinn, Ian
Owen, Carolyn
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[2] Med Univ Lodz, Lodz, Poland
[3] Med Univ Lublin, Lublin, Poland
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Kaiser Permanente Med Grp, Denver, CO USA
[6] St James Hosp, Dublin, Ireland
[7] CHU Toulouse, Toulouse, France
[8] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[9] Kaiser Hosp San Diego, San Marcos, CA USA
[10] St George Hosp, Cammeray, Australia
[11] Stanford Univ, Stanford, CA 94305 USA
[12] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[13] Hosp Univ La Princesa, Madrid, Spain
[14] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[15] Sarah Cannon Res Inst, Hematol Malignancies Res Program, Nashville, TN USA
[16] Alberta Hlth Serv, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.7515
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7515
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A phase II study of lenalidomide in previously untreated, symptomatic chronic lymphocytic leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Mariela, Pantoja
    Brandwein, Joseph
    Kukreti, Vishal
    Trudel, Suzanne
    Wei, Ellen
    Tong, Jieffei
    Moran, Mike
    BLOOD, 2007, 110 (11) : 608A - 608A
  • [42] Cost-Effectiveness Analysis of Obinutuzumab Versus Ofatumumab for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
    Reyes, Carolina
    Gazauskas, Gregory
    Becker, Ursula
    Moreno, Santiago
    Veenstra, David L.
    BLOOD, 2014, 124 (21)
  • [43] A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia
    Donnellan, William
    Berdeja, Jesus G.
    Shipley, Diana
    Arrowsmith, Edward R.
    Wright, David
    Lunin, Scott
    Brown, Richard
    Essell, James H.
    Flinn, Ian W.
    ONCOLOGIST, 2017, 22 (10): : 1156 - +
  • [44] A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients
    Hebb, Jonathan
    Assouline, Sarit
    Rousseau, Caroline
    DesJardins, Pierre
    Caplan, Stephen
    Egorin, Merrill J.
    Amrein, Lilian
    Aloyz, Raquel
    Panasci, Lawrence
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 643 - 651
  • [45] Activity and Tolerability of Ibrutinib in Combination With Ofatumumab in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
    Jaglowski, Samantha M.
    Jones, Jeffrey A.
    Flynn, Joseph M.
    Andritsos, Leslie A.
    Maddocks, Kami J.
    Woyach, Jennifer A.
    Blum, Kristie A.
    Greyer, Michael R.
    Geyer, Susan Michelle
    Heerema, Nyla A.
    Lozanski, Gerard
    Stefanos, Mona
    Hall, Nathan
    Nagar, Veena
    Munneke, Brian
    West, Jamie-Sue
    Neuenburg, Jutta K.
    James, Danelle F.
    Johnson, Amy J.
    Byrd, John C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S206 - S207
  • [46] A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients
    Jonathan Hebb
    Sarit Assouline
    Caroline Rousseau
    Pierre DesJardins
    Stephen Caplan
    Merrill J. Egorin
    Lilian Amrein
    Raquel Aloyz
    Lawrence Panasci
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 643 - 651
  • [47] Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial
    Knauf, Wolfgang U.
    Lissitchkov, Toshko
    Aldaoud, Ali
    Liberati, Anna M.
    Loscertales, Javier
    Herbrecht, Raoul
    Juliusson, Gunnar
    Postner, Gerhard
    Gercheva, Liana
    Goranov, Stefan
    Becker, Martin
    Fricke, Hans-Joerg
    Huguet, Francoise
    Del Giudice, Ilaria
    Klein, Peter
    Merkle, Karlheinz
    Montillo, Marco
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (01) : 67 - 77
  • [48] An Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Snitzler, Susi
    Le, Lisa W.
    Wei, Ellen Nong
    Lau, Anthea
    Johnston, James B.
    Gibson, Spencer B.
    Queau, Michelle L.
    Trudel, Suzanne
    BLOOD, 2015, 126 (23)
  • [49] IBRUTINIB COMBINED WITH BENDAMUSTINE/RITUXIMAB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): FIRST RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY
    Cramer, P.
    Chanan-Khan, A.
    Demirkan, F.
    Fraser, G.
    Santucci Silva, R.
    Pylypenko, H.
    Grosicki, S.
    Janssens, A.
    Pristupa, A.
    Mayer, J.
    Dilhuydy, M. S.
    Loscertales, J.
    Bartlett, N. L.
    Avigdor, A.
    Rule, S.
    Sun, S.
    Mahler, M.
    Salman, M.
    Howes, A.
    Hallek, M.
    HAEMATOLOGICA, 2015, 100 : 55 - 56
  • [50] A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib and rituximab for previously treated patients with chronic lymphocytic leukaemia (CLL) (NCRN375)
    Hillmen, P.
    Furman, R.
    Sharmann, J.
    Coutre, S.
    Cheson, B.
    Pagel, J.
    Barrientos, J. M.
    Zelenetz, A.
    Kipps, T.
    Pettitt, A.
    Wallis, J.
    Duncombe, A.
    Dearden, C.
    Follows, G.
    MacDonald, D.
    Moosa, A.
    Panoskaltsis, N.
    De Lord, C.
    McCarthy, H.
    O'Brien, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 : 3 - 3
12345